These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5690883)

  • 1. Phenobarbital prophylaxis for erythroblastosis.
    Kagan A; Kodsi B
    N Engl J Med; 1968 Aug; 279(5):271. PubMed ID: 5690883
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prophylactic and therapeutic value of Sevenal in the prevention and treatment of icterus gravis neonatorum].
    Gagyi D; Frank K
    Orv Hetil; 1971 Mar; 112(11):632-4. PubMed ID: 5103900
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of transitory hyperbilirubinemia of the premature and mature newborn infants and of the hemolytic disease of the newborn by an enzyme induction combination: phenobarbital-nikethamide].
    Kintzel HW; Schwarze R; Hinkel GK
    Schweiz Med Wochenschr; 1972 Sep; 102(38):1339-45. PubMed ID: 4630163
    [No Abstract]   [Full Text] [Related]  

  • 4. [Phenobarbital in the pharmacotherapy of neonatal jaundices (a review of the literature)].
    Skakun NP; Oleĭnik AN; Skakun GK; Dannik LM
    Vopr Okhr Materin Det; 1973 Sep; 18(9):36-8. PubMed ID: 4206063
    [No Abstract]   [Full Text] [Related]  

  • 5. Jaundice of the newborn and phenobarbitone.
    Lancet; 1971 Jan; 1(7690):119-20. PubMed ID: 4099609
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of fetal Rh-erythroblastosis using the enzyme inductor combination of phenobarbital-nicethamide].
    Kintzel HW; Hinkel GK; Schwarze R; Händel A; Böttger D
    Dtsch Gesundheitsw; 1972 Jul; 27(30):1405-8. PubMed ID: 4673197
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pediatric aspects of success and failure of anti-D-prophylaxis].
    Fürnkranz H; Rosenkranz A
    Wien Med Wochenschr; 1983 Dec; 133(23-24):607-10. PubMed ID: 6666162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis of neonatal hyperbilirubinemia with phenobarbital.
    Halpin TF; Jones AR; Bishop HL; Lerner S
    Obstet Gynecol; 1972 Jul; 40(1):85-90. PubMed ID: 4625595
    [No Abstract]   [Full Text] [Related]  

  • 9. [Advances in neonatology: vitamin K, intracranial hemorrhage, arterial pressure, hemolytic disease].
    Jiménez R
    An Esp Pediatr; 1984 Oct; 21(5):447-52. PubMed ID: 6095712
    [No Abstract]   [Full Text] [Related]  

  • 10. [Phenobarbital therapy of icterus neonatorium].
    Windorfer A
    Dtsch Med Wochenschr; 1970 Jul; 95(31):1617-9. PubMed ID: 5431985
    [No Abstract]   [Full Text] [Related]  

  • 11. [Enzyme induction using phenobarbital in newborn infants with hemolytic disease of newborn due to Rh incompatibility].
    Menzel K; Braun W
    Dtsch Gesundheitsw; 1972 Feb; 27(8):372-5. PubMed ID: 4623217
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current treatment of fetal erythroblastosis].
    Gligorović S; Gligorović V; Radojković Z; Majstorović M; Lopicić L; Marković P; Ivanović L; Janev A; Erac O
    Bilt Hematol Transfuz; 1977; 5(1):43-9. PubMed ID: 921731
    [No Abstract]   [Full Text] [Related]  

  • 13. [Phototherapy and treatment with phenobarbital in hemolytic disease of newborn due to Rh-incompatibility].
    Menzel K; Schambach K; Töpke B
    Acta Paediatr Acad Sci Hung; 1974; 15(3-4):333-9. PubMed ID: 4219868
    [No Abstract]   [Full Text] [Related]  

  • 14. Phenobarbitone in rhesus haemolytic disease.
    McMullin GP
    Lancet; 1970 Dec; 2(7684):1194-5. PubMed ID: 4098471
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of phenobarbital, adenosine triphosphate and hemodesis in the treatment of hemolytic disease of newborn].
    Dobronravov AV; Leshkevich IA
    Vopr Okhr Materin Det; 1979 Jan; 24(1):44-9. PubMed ID: 571170
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prophylaxis and prenatal treatment of fetal erythroblastosis in pregnancy. A trial of polyvinylpyrrolidone. Preliminary report].
    Fuleston JE; Curto AD; De Dahinten N
    Prensa Med Argent; 1965 Jun; 52(21):1370-1. PubMed ID: 5891784
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pathochemical principles of therapy in hemolytic disease of the newborn].
    Kalinicheva VI; Filippov ES; Panchenko AI; Bashnina EB
    Pediatriia; 1984 Nov; (11):53-8. PubMed ID: 6441922
    [No Abstract]   [Full Text] [Related]  

  • 18. Phenobarbitone in rhesus haemolytic disease. A controlled trial.
    McMullin GP; Hayes MF; Arora SC
    Lancet; 1970 Nov; 2(7680):949-52. PubMed ID: 4097596
    [No Abstract]   [Full Text] [Related]  

  • 19. Controlled trials of phenobarbitone therapy of neonatal jaundice.
    Ramboer C; Thompson RP; Williams R
    Lancet; 1969 May; 1(7602):966-8. PubMed ID: 4180816
    [No Abstract]   [Full Text] [Related]  

  • 20. [Erythroblastosis problems; Rh antibody titres and serum tocopherol, their relationship to placental histopathology in fetal erythroblastosis; and a contribution to erythroblastosis prophylaxis with vitamin E].
    BECKMANN R; FELDMANN F; SCHUMMELFEDER N
    Dtsch Med Wochenschr; 1954 Jul; 79(31-32):1157-62. PubMed ID: 13200190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.